Satellos Bioscience Inc.
MSCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $57,659 | $22,067 | $1,924 | $4,871 |
| Short-Term Investments | $12,195 | $17,520 | $0 | $0 |
| Receivables | $626 | $583 | $260 | $528 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,532 | $0 | $49 | $44 |
| Total Curr. Assets | $73,012 | $40,322 | $2,233 | $5,443 |
| Property Plant & Equip (Net) | $5 | $19 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $583 | $3,916 | $7,135 |
| Long-Term Investments | $0 | $41 | $42 | $0 |
| Tax Assets | $0 | $0 | -$42 | $0 |
| Other NC Assets | $0 | $0 | $42 | $0 |
| Total NC Assets | $5 | $3,976 | $3,966 | $7,143 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $73,017 | $44,298 | $6,199 | $12,586 |
| Liabilities | – | – | – | – |
| Payables | $2,968 | $1,040 | $1,466 | $885 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,187 | $2,584 | $1,364 | $975 |
| Total Curr. Liab. | $5,155 | $3,624 | $2,830 | $2,104 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5,155 | $3,624 | $2,830 | $2,104 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $105,729 | $61,916 | $30,209 | $28,316 |
| Retained Earnings | -$75,601 | -$47,502 | -$31,614 | -$20,291 |
| AOCI | -$217 | -$15 | -$7 | -$1 |
| Other Equity | $37,951 | $26,275 | $4,780 | $2,459 |
| Total Equity | $67,862 | $40,674 | $3,369 | $10,482 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $73,017 | $44,298 | $6,199 | $12,586 |
| Net Debt | -$57,659 | -$22,067 | -$1,924 | -$4,871 |